Literature DB >> 19273793

The spectrum of retinal diseases caused by NR2E3 mutations in Israeli and Palestinian patients.

Dikla Bandah1, Saul Merin, Munther Ashhab, Eyal Banin, Dror Sharon.   

Abstract

OBJECTIVES: To evaluate the involvement of NR2E3 in inherited retinal degenerative diseases in the Israeli and Palestinian populations and to study phenotypic variability in patients who are homozygous for the same mutation.
METHODS: Patients from 35 families underwent clinical evaluation, including a full ophthalmologic examination and electroretinography. Genetic analyses included direct sequencing of polymerase chain reaction products and haplotype reconstruction.
RESULTS: We recruited 6 consanguineous Muslim families and 2 Jewish families with enhanced S-cone syndrome. Patients from 4 of the Muslim families were homozygous for the same NR2E3 mutation, c.119-2A>C, but showed considerable variability in fundus appearance and retinal function, even among patients of comparable ages. Both Jewish patients were compound heterozygotes for the c.932G>A mutation in combination with c.194-202del9bp or a novel splice-site mutation, c.747+1G>C. Homozygosity analysis in 27 consanguineous families with retinitis pigmentosa revealed a homozygous mutation, c.932G>A, in 2 families. The electroretinographic responses in these patients were compatible with retinitis pigmentosa and did not show the characteristic enhanced S-cone syndrome pattern.
CONCLUSION: Our results demonstrate the involvement of NR2E3 in enhanced S-cone syndrome and retinitis pigmentosa phenotypes in our populations. CLINICAL RELEVANCE: Patients with NR2E3 mutations may manifest variable phenotypes. Moreover, patients who are homozygous for the same NR2E3 mutation have variable expression of retinal disease, suggesting the involvement of modifier genes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19273793     DOI: 10.1001/archophthalmol.2008.615

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  14 in total

1.  Electroretinography and optical coherence tomography reveal abnormal post-photoreceptoral activity and altered retinal lamination in patients with enhanced S-cone syndrome.

Authors:  M Sustar; D Perovšek; I Cima; B Stirn-Kranjc; M Hawlina; J Brecelj
Journal:  Doc Ophthalmol       Date:  2015-02-07       Impact factor: 2.379

2.  Enhanced S-cone syndrome with preserved macular structure and severely depressed retinal function.

Authors:  Ivan Cima; Jelka Brecelj; Maja Sustar; Frauke Coppieters; Bart P Leroy; Elfride De Baere; Marko Hawlina
Journal:  Doc Ophthalmol       Date:  2012-06-19       Impact factor: 2.379

3.  Novel clinical findings in autosomal recessive NR2E3-related retinal dystrophy.

Authors:  Vittoria Murro; Dario Pasquale Mucciolo; Andrea Sodi; Ilaria Passerini; Dario Giorgio; Gianni Virgili; Stanislao Rizzo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-10-15       Impact factor: 3.117

4.  Homozygosity mapping reveals null mutations in FAM161A as a cause of autosomal-recessive retinitis pigmentosa.

Authors:  Dikla Bandah-Rozenfeld; Liliana Mizrahi-Meissonnier; Chen Farhy; Alexey Obolensky; Itay Chowers; Jacob Pe'er; Saul Merin; Tamar Ben-Yosef; Ruth Ashery-Padan; Eyal Banin; Dror Sharon
Journal:  Am J Hum Genet       Date:  2010-08-12       Impact factor: 11.025

5.  Differential dimerization of variants linked to enhanced S-cone sensitivity syndrome (ESCS) located in the NR2E3 ligand-binding domain.

Authors:  Désirée von Alpen; Hoai Viet Tran; Nicolas Guex; Giulia Venturini; Francis L Munier; Daniel F Schorderet; Neena B Haider; Pascal Escher
Journal:  Hum Mutat       Date:  2015-04-27       Impact factor: 4.878

6.  New truncation mutation of the NR2E3 gene in a Japanese patient with enhanced S-cone syndrome.

Authors:  Kazuki Kuniyoshi; Takaaki Hayashi; Hiroyuki Sakuramoto; Hiroshi Mishima; Hiroshi Tsuneoka; Kazushige Tsunoda; Takeshi Iwata; Yoshikazu Shimomura
Journal:  Jpn J Ophthalmol       Date:  2016-08-13       Impact factor: 2.447

7.  Nuclear receptor Rev-erb alpha (Nr1d1) functions in concert with Nr2e3 to regulate transcriptional networks in the retina.

Authors:  Nissa J Mollema; Yang Yuan; Austin S Jelcick; Andrew J Sachs; Désirée von Alpen; Daniel Schorderet; Pascal Escher; Neena B Haider
Journal:  PLoS One       Date:  2011-03-08       Impact factor: 3.240

8.  Mutations in TULP1, NR2E3, and MFRP genes in Indian families with autosomal recessive retinitis pigmentosa.

Authors:  Chitra Kannabiran; Hardeep Singh; Nishika Sahini; Subhadra Jalali; Gayathri Mohan
Journal:  Mol Vis       Date:  2012-05-04       Impact factor: 2.367

9.  Developmental or degenerative--NR2E3 gene mutations in two patients with enhanced S cone syndrome.

Authors:  Nitin Udar; Kent Small; Meenal Chalukya; Rosamaria Silva-Garcia; Michael Marmor
Journal:  Mol Vis       Date:  2011-02-17       Impact factor: 2.367

10.  Modifier genes as therapeutics: the nuclear hormone receptor Rev Erb alpha (Nr1d1) rescues Nr2e3 associated retinal disease.

Authors:  Nelly M Cruz; Yang Yuan; Barrett D Leehy; Rinku Baid; Uday Kompella; Margaret M DeAngelis; Pascal Escher; Neena B Haider
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.